Clinical implications of endotoxin activity and Polymyxin‐B hemoperfusion in critically ill patients with septic cardiomyopathy: A single‐center, retrospective, observational study
Artificial Organs · 2023
DOI: 10.1111/aor.14645 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Artificial Organs, 2023. Verfasst von Salvatore Lucio Cutuli und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, Intensive Care Medicine and Anesthesiology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Hemoperfusion, Shock, Septic, Sepsis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Background
To explore the association between endotoxin activity (EA) and septic cardiomyopathy (SCM), the relationship between endotoxin removal by Polymyxin‐B hemoperfusion (PMX‐HP) and recovery from SCM (R‐SCM), and the correlation between R‐SCM and the 28‐day mortality in septic patients admitted to the intensive care unit (ICU).
Methods
Observational study that included patients admitted to two ICUs of a tertiary university hospital between April 2011 and December 2019, who received PMX‐HP for sepsis/septic shock. The SCM and R‐SCM were assessed by transthoracic echocardiography.
Results
Among 148 patients, SCM was diagnosed in 60 (46%) of them and had no relationship with median EA (SCM group: 0.73; no‐SCM group: 0.66, p = 0.48). Recovery from SCM was observed in 24 patients (49%) and was independently associated with the PMX‐HP (OR 4.19, 95%CI [1.22, 14.3]; p = 0.02) and the SAPS2 II score (OR 0.94, 95%CI [0.9, 0.98]; p = 0.006). In the SCM group, the 28‐day mortality was 60% and was independently predicted by R‐SCM (OR 0.02, 95%CI [0.001, 0.3] p = 0.005) and SAPS II score (OR 1.11, 95%CI [1.01, 1.23] p = 0.037).
Conclusions
In septic patients, EA was not associated with SCM. However, endotoxin removal by Polymyxin‐B hemoperfusion was associated with recovery from cardiomyopathy, which was a predictor of lower 28‐day mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency, Intensive Care Medicine and Anesthesiology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- Institute of Anesthesiology and Intensive Care Medicine, Università Cattolica del Sacro Cuore, Rome, Italy.
- Department of Anesthesiology and Intensive Care Medicine, Infermi Hospital, Rimini, Italy.
- Department of Anesthesiology and Intensive Care Medicine, S. Luca Hospital, Lucca, Italy.
- Department of Emergency and Critical Care, Santa Maria Nuova Hospital, Florence, Italy.
ORCID-Profile: Salvatore Lucio Cutuli
Zitieren
APA
Cutuli, S. L., Carelli, S., Cascarano, L., Cicconi, S., Silvestri, D., Cicetti, M., Vallecoccia, M. S., Pintaudi, G., Tanzarella, E. S., Grieco, D. L., Antonelli, M., & De Pascale, G. (2023). Clinical implications of endotoxin activity and Polymyxin‐B hemoperfusion in critically ill patients with septic cardiomyopathy: A single‐center, retrospective, observational study. Artificial Organs. https://doi.org/10.1111/aor.14645
Vancouver
Cutuli SL, Carelli S, Cascarano L, Cicconi S, Silvestri D, Cicetti M, et al. Clinical implications of endotoxin activity and Polymyxin‐B hemoperfusion in critically ill patients with septic cardiomyopathy: A single‐center, retrospective, observational study. Artificial Organs. 2023. doi:10.1111/aor.14645
BibTeX
@article{Cutuli2023,
author = {Cutuli, Salvatore Lucio and Carelli, Simone and Cascarano, Laura and Cicconi, Sandra and Silvestri, Davide and Cicetti, Marta and Vallecoccia, Maria Sole and Pintaudi, Gabriele and Tanzarella, Eloisa Sofia and Grieco, Domenico Luca and Antonelli, Massimo and De Pascale, Gennaro},
title = {Clinical implications of endotoxin activity and Polymyxin‐B hemoperfusion in critically ill patients with septic cardiomyopathy: A single‐center, retrospective, observational study},
journal = {Artificial Organs},
year = {2023},
doi = {10.1111/aor.14645}
}
EUVIMED